**Exhibit
      31.2**


**Certification
      of Chief Financial Officer Pursuant to Rule 13a-14(a)**


**of
      the Securities Exchange Act of 1934**





I,
      Daniel
      R. Ouzts, certify that:





1.  I
      have
      reviewed this annual report on Form 10-K of Dialysis Corporation of
      America;





2.  Based
      on
      my knowledge, this annual report does not contain any untrue statement of a
      material fact or omit to state a material fact necessary to make the statements
      made, in light of the circumstances under which such statements were made,
      not
      misleading with respect to the period covered by this annual
      report;





3.  Based
      on my
      knowledge, the financial statements, and other financial information included
      in
      this annual report, fairly present in all material respects the financial
      condition, results of operations and cash flows of the registrant as of, and
      for, the periods presented in this annual report;





4.  The
      registrant’s other certifying officer and I are responsible for establishing and
      maintaining disclosure controls and procedures (as defined in Exchange Act
      Rules
      13a-15(e) and 15d-15(e)) for the registrant and we have:





(a)  Designed
      such disclosure controls and procedures, or caused such disclosure controls
      and
      procedures to be designed under our supervision, to ensure that material
      information relating to the registrant, including its consolidated subsidiaries,
      is made known to us by others within those entities, particularly during the
      period in which this annual report is being prepared;





(b)  Evaluated
      the effectiveness of the registrant’s disclosure controls and procedures and
      presented in this annual report our conclusions about the effectiveness of
      the
      disclosure controls and procedures as of the end of the period covered by this
      annual report based on such evaluation; and





(c)  Disclosed
      in this report any change in the registrant’s internal control over financial
      reporting that occurred during the registrant’s most recent fiscal quarter (the
      registrant’s fourth fiscal quarter in the case of any annual report) that has
      materially affected, or is reasonably likely to materially affect, the
      registrant’s internal control over financial reporting;





5.  The
      registrant’s other certifying officer and I have disclosed, based on our most
      recent evaluation of internal control over financial reporting, to the
      registrant’s auditors and the audit committee of registrant’s board of directors
      (or persons performing the equivalent functions):





(a)  All
      significant deficiencies and material weaknesses in the design or operation
      of
      internal control over financial reporting which are reasonably likely to
      adversely affect the registrant’s ability to record, process, summarize and
      report financial information; and





(b)  Any
      fraud,
      whether or not material, that involves management or other employees who have
      a
      significant role in the registrant’s internal control over financial
      reporting.




Date: March
              30, 2006
            
            /s/
              Daniel R. OuztsDANIEL R. OUZTS, Chief Financial Officer